Giuseppe Ciaramella
@gciaramella1
ID: 1341364838
10-04-2013 08:30:33
167 Tweet
379 Takipçi
87 Takip Edilen
Excited to share the news for this collaboration with Apellis Pharma using base editing to treat complement-driven diseases, in line with the potential of base editing to not only treat rare diseases caused by point mutations but also to modulate complex biological systems